Kensico Capital Management Corp Sells 44,530 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Kensico Capital Management Corp lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 225,470 shares of the healthcare conglomerate’s stock after selling 44,530 shares during the quarter. UnitedHealth Group comprises about 2.6% of Kensico Capital Management Corp’s investment portfolio, making the stock its 15th biggest position. Kensico Capital Management Corp’s holdings in UnitedHealth Group were worth $114,056,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of UNH. Czech National Bank raised its position in shares of UnitedHealth Group by 6.1% in the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after purchasing an additional 11,426 shares during the period. Aprio Wealth Management LLC raised its holdings in UnitedHealth Group by 15.9% in the 4th quarter. Aprio Wealth Management LLC now owns 1,337 shares of the healthcare conglomerate’s stock worth $676,000 after acquiring an additional 183 shares during the period. Matrix Trust Co boosted its holdings in UnitedHealth Group by 6.6% during the fourth quarter. Matrix Trust Co now owns 3,634 shares of the healthcare conglomerate’s stock valued at $1,838,000 after acquiring an additional 225 shares during the period. Winthrop Advisory Group LLC lifted its position in shares of UnitedHealth Group by 2.4% during the 4th quarter. Winthrop Advisory Group LLC now owns 1,301 shares of the healthcare conglomerate’s stock worth $658,000 after purchasing an additional 31 shares during the last quarter. Finally, Fiduciary Alliance LLC lifted its holdings in shares of UnitedHealth Group by 260.7% during the fourth quarter. Fiduciary Alliance LLC now owns 9,893 shares of the healthcare conglomerate’s stock worth $5,005,000 after buying an additional 7,150 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $380.72 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average is $488.01 and its 200-day moving average is $522.31. UnitedHealth Group Incorporated has a 1 year low of $378.54 and a 1 year high of $630.73. The firm has a market capitalization of $346.54 billion, a price-to-earnings ratio of 24.56, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the firm earned $6.91 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.18%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on UNH. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Oppenheimer decreased their price objective on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday, April 21st. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Four equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.